Pfizer and BioNTech to Supply Additional 100 Million COVID-19 Vaccine Doses to European Union

Strategic Insights -

Pfizer Inc. and BioNTech SE have announced plans to supply an additional 100 million doses of the COVID-19 vaccine, COMIRNATY, to the European Union (EU) in 2021. This decision comes as a result of the European Commission's exercise of its option to purchase an additional 100 million doses under the Advanced Purchase Agreement signed on November 11, 2020. The total number of doses to be delivered to the EU now stands at 300 million. According to Albert Bourla, Chairman and Chief Executive Officer of Pfizer, the companies remain committed to delivering the vaccine quickly and safely to more people in Europe, where the virus continues to spread rapidly. In partnership with the European Commission, member states, and healthcare providers, Pfizer and BioNTech aim to reach a total of 150 million Europeans across the continent through the vaccination campaigns.

Key Takeaways:

  • Pfizer and BioNTech will supply an additional 100 million doses of the COVID-19 vaccine, COMIRNATY, to the European Union in 2021.
  • The announcement is a result of the European Commission's exercise of its option to purchase an additional 100 million doses under the Advanced Purchase Agreement signed on November 11, 2020.
  • The total number of doses to be delivered to the EU now stands at 300 million.
  • Albert Bourla, Chairman and Chief Executive Officer of Pfizer, emphasized the companies' commitment to delivering the vaccine quickly and safely to more people in Europe.
  • The additional 100 million doses will support the vaccination campaigns across the 27 EU member states.
  • The vaccine will be produced in BioNTech's and Pfizer's manufacturing sites in Europe, with distribution determined by EU and national guidance.

Statistics:

  • 300 million: Total number of dose deliveries to the EU (including the additional 100 million doses).
  • 100 million: Additional dose deliveries to the EU in 2021.
  • 150 million: Total number of Europeans expected to be vaccinated across the continent.
  • 2021: Year of expected delivery for the additional 100 million doses.
  • 200 million: Initial dose deliveries agreed upon with the European Commission on November 11, 2020.
  • 1.3 billion: Total potential dose deliveries worldwide by the end of 2021 (subject to manufacturing capacity).

Sources:

  • Pfizer Inc.
  • BioNTech SE
  • European Commission
  • Al Bawaba (Albawaba.com)
  • SyndiGate Media Inc. (Syndigate.info)